Myocardial cytokine IL-8 and nitric oxide synthase activity during and after resuscitation: preliminary observations in regards to post-resuscitation myocardial dysfunction.

[1]  G. Lamas,et al.  Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: vital or protective? , 2007, Resuscitation.

[2]  N. Westerhof,et al.  Nitric oxide and cardiac function. , 2007, Life sciences.

[3]  G. Lamas,et al.  Different roles of nitric oxide synthase isoforms in cardiopulmonary resuscitation in pigs. , 2007, Resuscitation.

[4]  R. Kerber,et al.  Effect of nitric oxide synthase modulation on resuscitation success in a swine ventricular fibrillation cardiac arrest model. , 2005, Resuscitation.

[5]  R. Kerber,et al.  The nitric oxide donor S-nitroso-N-acetylpenicillamine (SNAP) increases free radical generation and degrades left ventricular function after myocardial ischemia-reperfusion. , 2003, Resuscitation.

[6]  Simon C Watkins,et al.  Characterization of the Expression of Inducible Nitric Oxide Synthase in Rat and Human Liver During Hemorrhagic Shock , 2003, Shock.

[7]  J. Chiche,et al.  Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. , 2002, Journal of the American College of Cardiology.

[8]  Anand Kumar,et al.  Clinical review: Myocardial depression in sepsis and septic shock , 2002, Critical care.

[9]  J. Cavaillon,et al.  Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome , 2002, Circulation.

[10]  Simon C Watkins,et al.  The Modulation of Hepatic Injury and Heat Shock Expression by Inhibition of Inducible Nitric Oxide Synthase After Hemorrhagic Shock , 2002, Shock.

[11]  T. Sakamoto,et al.  Significance of elevated serum interleukin-8 in patients resuscitated after cardiopulmonary arrest. , 2001, Resuscitation.

[12]  J. Parrillo,et al.  Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. , 2001, Journal of cardiothoracic and vascular anesthesia.

[13]  R. Kerber,et al.  Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. , 2001, Journal of the American College of Cardiology.

[14]  V. Wenzel,et al.  Inhibition of nitric oxide improves coronary perfusion pressure and return of spontaneous circulation in a porcine cardiopulmonary resuscitation model , 2001, Critical care medicine.

[15]  S. Goldman,et al.  Gene transfer of endothelial nitric oxide isoform decreases rat hindlimb vascular resistance in vivo. , 2000, Human gene therapy.

[16]  J E Parrillo,et al.  Myocardial dysfunction in septic shock. , 2000, Critical care clinics.

[17]  B. Reichart,et al.  Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. , 1999, Cardiovascular research.

[18]  Xiangru Lu,et al.  Effects of L-arginine on endothelial and cardiac function in rats with heart failure. , 1999, European journal of pharmacology.

[19]  Simon C Watkins,et al.  A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. , 1999, The American journal of physiology.

[20]  A. Harken,et al.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. , 1999, Critical care medicine.

[21]  B. Reichart,et al.  Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion--implications for iNOS-mediated myocardial stunning. , 1999, The Thoracic and cardiovascular surgeon.

[22]  S. Goldman,et al.  Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo. , 1999, Journal of molecular and cellular cardiology.

[23]  H. Drexler,et al.  Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. , 1998, Journal of the American College of Cardiology.

[24]  A. Peitzman,et al.  Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock , 1998, The Journal of experimental medicine.

[25]  K. Shyu,et al.  Concentrations of serum interleukin-8 after successful cardiopulmonary resuscitation in patients with cardiopulmonary arrest. , 1997, American heart journal.

[26]  C. Otto,et al.  Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. , 1997, Circulation.

[27]  Z. Naito,et al.  Differential distribution of ecNOS and iNOS mRNA in rat heart after endotoxin administration. , 1997, Japanese heart journal.

[28]  F. Colardyn,et al.  Left ventricular systolic and diastolic function in septic shock , 1997, Intensive Care Medicine.

[29]  R. Berg,et al.  Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. , 1996, Journal of the American College of Cardiology.

[30]  Anand Kumar,et al.  Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum , 1996, The Journal of experimental medicine.

[31]  S. Lewis.  Survival after failed out-of-hospital resuscitation , 1995 .

[32]  R. Schoenenberger,et al.  Survival after failed out-of-hospital resuscitation. Are further therapeutic efforts in the emergency department futile? , 1994, Archives of internal medicine.

[33]  A. Yao,et al.  Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes. , 1994, Circulation research.

[34]  S. Opal,et al.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. , 1994, JAMA.

[35]  R. F. Johnston,et al.  Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .

[36]  K. Walley,et al.  Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs. , 1994, Journal of applied physiology.

[37]  S. Opal,et al.  Initial evaluation of human recombinant interleukin‐1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open‐label, placebocontrolled multicenter trial , 1994, Critical care medicine.

[38]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[39]  Gaëtan Marecaux,et al.  Clinical Investigations in Critical CareAdministration of Anti-TNF Antibody Improves Left Ventricular Function in Septic Shock Patients: Results of a Pilot Study , 1992 .

[40]  S. Moncada,et al.  Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardium , 1992, British journal of pharmacology.

[41]  G A Ewy,et al.  Depletion of myocardial adenosine triphosphate during prolonged untreated ventricular fibrillation: effect on defibrillation success. , 1990, Resuscitation.

[42]  G. Schreiner,et al.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Shelhamer,et al.  Profound but reversible myocardial depression in patients with septic shock. , 1984, Annals of internal medicine.

[44]  R. C. Dennis,et al.  Myocardial depression during sepsis. , 1977, American journal of surgery.

[45]  Brett M. Kissela,et al.  Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics—2006 Update: A Report From the American , 2009 .

[46]  R. Lewis,et al.  Tumor necrosis factor-alpha is associated with early postresuscitation myocardial dysfunction. , 2004, Critical care medicine.

[47]  S. Moncada,et al.  Expression of inducible nitric oxide synthase in human heart failure. , 1997, Circulation.

[48]  J. Balligand,et al.  Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. , 1995, Journal of molecular and cellular cardiology.

[49]  R. Rothery,et al.  Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013Peroxynitrite Is a Major Contributor to Cytokine-Induced , 2022 .